コンテンツへスキップ
Merck
  • Diverse intracellular pathogens activate type III interferon expression from peroxisomes.

Diverse intracellular pathogens activate type III interferon expression from peroxisomes.

Nature immunology (2014-06-24)
Charlotte Odendall, Evelyn Dixit, Fabrizia Stavru, Helene Bierne, Kate M Franz, Ann Fiegen Durbin, Steeve Boulant, Lee Gehrke, Pascale Cossart, Jonathan C Kagan
要旨

Type I interferon responses are considered the primary means by which viral infections are controlled in mammals. Despite this view, several pathogens activate antiviral responses in the absence of type I interferons. The mechanisms controlling type I interferon-independent responses are undefined. We found that RIG-I like receptors (RLRs) induce type III interferon expression in a variety of human cell types, and identified factors that differentially regulate expression of type I and type III interferons. We identified peroxisomes as a primary site of initiation of type III interferon expression, and revealed that the process of intestinal epithelial cell differentiation upregulates peroxisome biogenesis and promotes robust type III interferon responses in human cells. These findings highlight the importance of different intracellular organelles in specific innate immune responses.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
モノクロナール抗β-アクチン マウス宿主抗体, clone AC-15, ascites fluid
Sigma-Aldrich
抗αチューブリン抗体、マウスモノクローナル, clone B-5-1-2, purified from hybridoma cell culture
Sigma-Aldrich
抗PMP70抗体、マウスモノクローナル, clone 70-18, purified from hybridoma cell culture
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Mavs
Sigma-Aldrich
MISSION® esiRNA, targeting human IRF3